Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?

Journal of Internal Medicine

Volumn 259, Issue 3, 2006, Pages 219-246

  Soderberg Naucler C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmune disease; Cancer; Cardiovascular disease; Cytomegalovirus; Immune evasion; Inflammation

Indexed keywords

ACICLOVIR; FOSCARNET; GANCICLOVIR;

AIDS PATIENT; ANGIOGENESIS; APOPTOSIS; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CANCER INVASION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL MIGRATION; EPIGENETICS; EVOLUTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INFLAMMATORY DISEASE; LATENT VIRUS INFECTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS SURVIVAL;

ANIMALS; AUTOIMMUNE DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; NEOPLASMS; VASCULAR DISEASES; VIRUS ACTIVATION;

EID: 33645099725     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01618.x     Document Type: Review

References (286)

1. Britt WJ Mach M Human cytomegalovirus glycoproteins Intervirology 1996 39 401 12
2. Britt WJ Alford CA Cytomegalovirus In Fields BN Knipe DM Howley PM eds Field's Virology Philadelphia, PA Lippincott-Raven Publishers 1996 2493 523
3. Grillner L Strangert K Restriction endonuclease analysis of cytomegalovirus DNA from strains isolated in day care centers Pediatr Infect Dis 1986 5 184 7
4. Onorato IM Morens DM Martone WJ Stansfield SK Epidemiology of cytomegaloviral infections: recommendations for prevention and control Rev Infect Dis 1985 7 479 97
5. Fowler KB Stagno S Pass RF Britt WJ Boll TJ Alford CA The outcome of congenital cytomegalovirus infection in relation to maternal antibody status N Engl J Med 1992 326 663 7
6. Mehta SK Stowe RP Feiveson AH Tyring SK Pierson DL Reactivation and shedding of cytomegalovirus in astronauts during spaceflight J Infect Dis 2000 182 1761 4
7. Stowe RP Mehta SK Ferrando AA Feeback DL Pierson DL Immune responses and latent herpesvirus reactivation in spaceflight Aviat Space Environ Med 2001 72 884 91
8. Heininger A Jahn G Engel C Notheisen T Unertl K Hamprecht K Human cytomegalovirus infections in nonimmunosuppressed critically ill patients Crit Care Med 2001 29 541 7
9. Jaber S Chanques G Borry J et al. Cytomegalovirus infection in critically ill patients: associated factors and consequences Chest 2005 127 233 41
10. Prosch S Wendt CE Reinke P et al. A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation Virology 2000 272 357 65
11. Soderberg-Naucler C Fish KN Nelson JA Interferon-gamma and tumour necrosis factor-alpha specifically induce formation of cytomegalovirus- permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines J Clin Invest 1997 100 3154 63
12. Soderberg-Naucler C Streblow DN Fish KN Allan-Yorke J Smith PP Nelson JA Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent J Virol 2001 75 7543 54
13. Torok-Storb B Fries B Stachel D Khaira D Cytomegalovirus: variations in tropism and disease Leukemia 1993 7 S83 5
14. Grattan MT Moreno-Cabral CE Starnes VA Oyer PE Stinson EB Shumway NE Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 1989 261 3561 6
15. Streblow DN Soderberg-Naucler C Vieira J et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration Cell 1999 99 511 20
16. Simmons P Kaushansky K Torok-Storb B Mechanisms of cytomegalovirus- mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells Proc Natl Acad Sci U S A 1990 87 1386 90
17. Söderberg C Larsson S Rozell BL Sumitran-Karuppan S Ljungman P Möller E Cytomegalovirus induced CD13 specific autoimmunity - a possible cause of chronic graft-versus-host disease Transplantation 1996 61 600 9
18. Lönnqvist B Ringden O Wahren B Gahrton G Lundgren G Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease Transplantation 1984 38 465 8
19. Bron D Lagneaux L Delforge A Otte C Snoeck R Stryckmans P Prevention of CMV-induced myelosuppression by anti-CMV antibodies: an in vitro model Exp Hematol 1991 19 132 5
20. Zhou YF Leon MB Waclawiw MA et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy N Engl J Med 1996 335 624 30
21. Melnick JL Adam E Debakey ME Cytomegalovirus and atherosclerosis Eur Heart J 1993 14 Suppl. K 30 8
22. Speir E Modali R Huang ES et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science 1994 265 391 4
23. Rahbar AR Sundqvist VA Wirgart BZ Crillner L Soderberg-Naucler C Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases Inflamm Bowel Dis 2003 9 154 61
24. Harkins L Volk AL Samanta M et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer Lancet 2002 360 1557 63
25. Samanta M Harkins L Klemm K Britt WJ Cobbs CS High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma J Urol 2003 170 998 1002
26. Cobbs CS Harkins L Samanta M et al. Human cytomegalovirus infection and expression in human malignant glioma Cancer Res 2002 62 3347 50
27. Dolan A Cunningham C Hector RD et al. Genetic content of wild-type human cytomegalovirus J Gen Virol 2004 85 Pt 5 1301 12
28. Hahn G Revello MG Patrone M et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes J Virol 2004 78 10023 33
29. Gerna G Percivalle E Lilleri D et al. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells J Gen Virol 2005 86 Pt 2 275 84
30. Taylor-Wiedeman J Sissons JG Borysiewicz LK Sinclair JH Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells J Gen Virol 1991 72 Pt 9 2059 64
31. Ibanez CE Schrier R Ghazal P Wiley C Nelson JA Human cytomegalovirus productively infects primary differentiated macrophages J Virol 1991 65 6581 8
32. Pulliam L Cytomegalovirus preferentially infects a monocyte derived macrophage/microglial cell in human brain cultures: neuropathology differs between strains J Neuropathol Exp Neurol 1991 50 432 40
33. Pulliam L Moore D West DC Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: possible role in neurotoxicity J Neurovirol 1995 1 219 27
34. Sinzger C Grefte A Plachter B Gouw AS The TH Jahn G Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues J Gen Virol 1995 76 Pt 4 741 50
35. Sinzger C Plachter B Grefte A The Th Jahn G Tissue macrophages are infected by human cytomegalovirus in vivo J Infect Dis 1996 173 240 5
36. Gnann JW Jr. Ahlmen J Svalander C Olding L Oldstone MB Nelson JA Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus Am J Pathol 1988 132 239 48
37. Jarvis MA Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages Curr Opin Microbiol 2002 5 403 7
38. Weinshenker BG Wilton S Rice GP Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line J Immunol 1988 140 1625 31
39. Gonczol E Andrews PW Plotkin SA Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells Science 1984 224 159 61
40. Soderberg-Naucler C Fish KN Nelson JA Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors Cell 1997 91 119 26
41. Taylor-Wiedeman J Sissons P Sinclair J Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers J Virol 1994 68 1597 604
42. Minton EJ Tysoe C Sinclair JH Sissons JG Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow J Virol 1994 68 4017 21
43. Maciejewski JP Bruening EE Donahue RE Mocarski ES Young NS St Jeor SC Infection of hematopoietic progenitor cells by human cytomegalovirus Blood 1992 80 170 8
44. Movassagh M Gozlan J Senechal B Baillou C Petit JC Lemoine FM Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication Blood 1996 88 1277 83
45. Sindre H Tjoonnfjord GE Rollag H et al. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells Blood 1996 88 4526 33
46. Mendelson M Monard S Sissons P Sinclair J Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors J Gen Virol 1996 77 Pt 12 3099 102
47. von Laer D Meyer-Koenig U Serr A et al. Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow Blood 1995 86 4086 90
48. Schrier RD Nelson JA Oldstone MB Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection Science 1985 230 1048 51
49. Brytting M Mousavi-Jazi M Bostrom L et al. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients Transplantation 1995 60 961 5
50. Soderberg C Larsson S Bergstedt-Lindqvist S Moller E Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection J Virol 1993 67 3166 75
51. Stein J Volk HD Liebenthal C Kruger DH Prosch S Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells J Gen Virol 1993 74 Pt 11 2333 8
52. Sambucetti LC Cherrington JM Wilkinson GW Mocarski ES NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation EMBO J 1989 8 4251 8
53. Prösch S Staak K Stein J Liebenthal C Stamminger T Volk KDH Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF-a is mediated via induction of NF-kB Virology 1995 208 197 206
54. Ritter T Brandt C Prosch S et al. Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells Cytokine 2000 12 1163 70
55. Prosch S Heine AK Volk HD Kruger DH CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation J Biol Chem 2001 276 40712 20
56. Zhang H Fu S Busch A Chen F Qin L Bromberg JS Identification of TNF-alpha-sensitive sites in HCMVie1 promoter Exp Mol Pathol 2001 71 106 14
57. Boldogh I Fons MP Albrecht T Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus-infected cells Biochem Biophys Res Commun 1993 197 1505 10
58. Yurochko AD Kowalik TF Huong SM Huang ES Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters J Virol 1995 69 5391 400
59. Yurochko AD Mayo MW Poma EE Baldwin AS Jr. Huang ES Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters J Virol 1997 71 4638 48
60. Laegreid A Medvedev A Nonstad U et al. Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer J Biol Chem 1994 269 7785 91
61. Prosch S Staak K Stein J et al. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB Virology 1995 208 197 206
62. Docke WD Prosch S Fietze E et al. Cytomegalovirus reactivation and tumour necrosis factor Lancet 1994 343 268 9
63. Docke WD Kiessling C Worm M et al. Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis Br J Dermatol 2003 148 954 63
64. Kutza AS Muhl E Hackstein H Kirchner H Bein G High incidence of active cytomegalovirus infection among septic patients Clin Infect Dis 1998 26 1076 82
65. Miller W Flynn P McCullough J et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease Blood 1986 67 1162 7
66. Koskinen PK Kallio EA Tikkanen JM Sihvola RK Hayry PJ Lemstrom KB Cytomegalovirus infection and cardiac allograft vasculopathy Transpl Infect Dis 1999 1 115 26
67. Lautenschlager I Hockerstedt K Taskinen E von Willebrand E Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection Transpl Int 1996 -9; ( Suppl.1 S213 5
68. Guyotat D Gibert R Chomel J et al. Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation J Med Virol 1987 23 393 9
69. Meijer E Boland GJ Verdonck LF Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants Clin Microbiol Rev 2003 16 647 57
70. Ricart MJ Malaise J Moreno A Crespo M Fernandez-Cruz L Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation Nephrol Dial Transplant 2005 20 Suppl. 2 ii25 ii32 ii62
71. Valantine H Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial J Heart Lung Transplant 2005 24 Suppl. S191 5 discussion S210 1
72. Nast CC Wilkinson A Rosenthal JT et al. Differentiation of cytomegalovirus infection from acute rejection using renal allograft fine needle aspirates J Am Soc Nephrol 1991 1 1204 11
73. Looney RJ Falsey A Campbell D et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals Clin Immunol 1999 90 213 9
74. Wikby A Johansson B Olsson J Lofgren S Nilsson BO Ferguson F Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study Exp Gerontol 2002 37 445 53
75. Dunn W Chou C Li H et al. Functional profiling of a human cytomegalovirus genome Proc Natl Acad Sci U S A 2003 100 14223 8
76. Leong CC Chapman TL Bjorkman PJ et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog [published erratum appears in J Exp Med 1998;188:614] J Exp Med 1998 187 1681 7
77. Odeberg J Cerboni C Browne H et al. Human cytomegalovirus (HCMV) infected endothelial cells and macrophages are less susceptible to NK lysis independently of downregulation of classical HLA class I molecules, or expression of the HCMV class I homologue, UL18 Scand J Immunol 2001 55 149 61
78. Reyburn HT Mandelboim O Vales-Gomez M Davis DM Pazmany L Strominger JL The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells [see comments] Nature 1997 386 514 7
79. Fletcher JM Prentice HG Grundy JE Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA J Immunol 1998 161 2365 74
80. Cerboni C Mousavi-Jazi M Linde A et al. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts J Immunol 2000 164 4775 82
81. Cerboni C Mousavi-Jazi M Wakiguchi H Carbone E Karre K Soderstrom K Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity Eur J Immunol 2001 31 2926 35
82. Tomasec P Braud VM Rickards C et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 Science 2000 287 1031
83. Odeberg J Browne H Metkar S et al. The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins J Virol 2003 77 4539 45
84. Grigoleit U Riegler S Einsele H et al. Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells Br J Haematol 2002 119 189 98
85. Moutaftsi M Mehl AM Borysiewicz LK Tabi Z Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells Blood 2002 99 2913 21
86. Varani S Frascaroli G Homman-Loudiyi M Feld S Landini MP Soderberg-Naucler C Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5 J Leukoc Biol 2005 77 219 28
87. Spencer JV Lockridge KM Barry PA et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10 J Virol 2002 76 1285 92
88. Chang WL Baumgarth N Yu D Barry PA Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality J Virol 2004 78 8720 31
89. Raftery MJ Wieland D Gronewald S Kraus AA Giese T Schonrich G Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10 J Immunol 2004 173 3383 91
90. Kotenko SV Saccani S Izotova LS Mirochnitchenko OV Pestka S Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) Proc Natl Acad Sci U S A 2000 97 1695 700
91. Gilbert MJ Riddell SR Plachter B Greenberg PD Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product Nature 1996 383 720 2
92. Gilbert MJ Riddell SR Li CR Greenberg PD Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus J Virol 1993 67 3461 9
93. Ahn K Angulo A Ghazal P Peterson PA Yang Y Fruh K Human cytomegalovirus inhibits antigen presentation by a sequential multistep process Proc Natl Acad Sci U S A 1996 93 10990 5
94. Jones TR Wiertz E Sun L Fish KN Nelson JA Ploegh HL Human cytomegalovirus Us3 impairs transport and maturation of major histocompatibility complex class I heavy chains Proc Natl Acad Sci U S A 1996 93 11327 33
95. Ahn K Gruhler A Galocha B et al. The Er luminal domain of the Hcmv glycoprotein Us6 inhibits peptide translocation by tap Immunity 1997 6 613 21
96. Hewitt EW Gupta SS Lehner PJ The human cytomegalovirus gene product US6 inhibits ATP binding by TAP EMBO J 2001 20 387 96
97. Hengel H Koopmann JO Flohr T et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter Immunity 1997 6 623 32
98. Lehner PJ Karttunen JT Wilkinson GW Cresswell P The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation Proc Natl Acad Sci U S A 1997 94 6904 9
99. Sedmak DD Guglielmo AM Knight DA Birmingham DJ Huang EH Waldman WJ Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells [see comments] Am J Pathol 1994 144 683 92
100. Miller DM Rahill BM Boss JM et al. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway J Exp Med 1998 187 675 83
101. Odeberg J Plachter B Branden L Soderberg-Naucler C Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain Blood 2003 101 4870 7
102. Odeberg J Soderberg-Naucler C Reduced expression of HLA class II molecules and interleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures J Virol 2001 75 5174 81
103. Tomazin R Boname J Hegde NR et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells Nat Med 1999 5 1039 43
104. Hegde NR Tomazin RA Wisner TW et al. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation J Virol 2002 76 10929 41
105. Schrier RD Rice GP Oldstone MB Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus J Infect Dis 1986 153 1084 91
106. Kapasi K Rice GP Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness J Virol 1988 62 3603 7
107. Carney WP Hirsch MS Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions J Infect Dis 1981 144 47 54
108. Wahren B Ljungman P Paulin T Ringden O Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro J Virol 1986 58 909 13
109. Furukawa T Hornberger E Sakuma S Plotkin SA Demonstration of immunoglobulin G receptors induced by human cytomegalovirus J Clin Microbiol 1975 2 332 6
110. Sakuma S Furukawa T Plotkin SA The characterization of IgG receptor induced by human cytomegalovirus Proc Soc Exp Biol Med 1977 155 168 72
111. MacCormac LP Grundy JE Human cytomegalovirus induces an Fc gamma receptor (Fc gammaR) in endothelial cells and fibroblasts that is distinct from the human cellular Fc gammaRs J Infect Dis 1996 174 1151 61
112. Xu B Murayama T Ishida K Furukawa T Characterization of IgG Fc receptors induced by human cytomegalovirus J Gen Virol 1989 70 Pt 4 893 900
113. Rahman AA Teschner M Sethi KK Brandis H Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus J Immunol 1976 117 253 8
114. Lilley BN Ploegh HL Tirabassi RS Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein J Virol 2001 75 11218 21
115. Atalay R Zimmermann A Wagner M et al. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs J Virol 2002 76 8596 608
116. Spiller OB Morgan BP Tufaro F Devine DV Altered expression of host encoded complement regulators on human cytomegalovirus infected cells Eur J Immunol 1996 26 1532 8
117. Spiller OB Hanna SM Devine DV Tufaro F Neutralization of cytomegalovirus virions: the role of complement J Infect Dis 1997 176 339 47
118. Spear GT Lurain NS Parker CJ Ghassemi M Payne GH Saifuddin M Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV) J Immunol 1995 155 4376 81
119. Dudding LR Garnett HM Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccharide stimulation J Infect Dis 1987 155 891 6
120. Moses AV Garnett HM The effect of human cytomegalovirus on the production and biologic action of interleukin-1 J Infect Dis 1990 162 381 8
121. Almeida GD Porada CD St Jeor S Ascensao JL Human cytomegalovirus alters interleukin-6 production by endothelial cells Blood 1994 83 370 6
122. Smith PD Saini SS Raffeld M Manischewitz JF Wahl SM Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages J Clin Invest 1992 90 1642 8
123. Turtinen Lw Assimacopoulos A Haase At Increased monokines in cytomegalovirus infected myelomonocytic cell cultures Microb Pathog 1989 7 135 45
124. Compton T Kurt-Jones EA Boehme KW et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2 J Virol 2003 77 4588 96
125. Penfold ME Dairaghi DJ Duke GM et al. Cytomegalovirus encodes a potent alpha chemokine Proc Natl Acad Sci U S A 1999 96 9839 44
126. Neote K DiGregorio D Mak JY Horuk R Schall TJ Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor Cell 1993 72 415 25
127. Chee MS Bankier AT Beck S et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169 Curr Top Microbiol Immunol 1990 154 125 69
128. Margulies BJ Browne H Gibson W Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles Virol 1996 225 111 25
129. Gao JL Murphy PM Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor J Biol Chem 1994 269 28539 42
130. Kuhn DE Beall CJ Kolattukudy PE The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity Biochem Biophys Res Commun 1995 211 325 30
131. Vieira J Schall TJ Corey L Geballe AP Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene J Virol 1998 72 8158 65
132. Nichols WG Corey L Gooley T Davis C Boeckh M High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection J Infect Dis 2002 185 273 82
133. George MJ Snydman DR Werner BG et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland Am J Med 1997 103 106 13
134. Griffin D Potential mechanisms of immune suppression In Nathanson N ed Viral Pathogenesis
135. Rinaldo C Jr. Carney WP Richter BS Black PH Hirsch MS Mechanisms of immunosuppression in cytomegaloviral mononucleosis J Infect Dis 1980 141 488 95
136. Levin MJ Rinaldo C Jr. Leary PL Zaia JA Hirsch MS Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis J Infect Dis 1979 140 851 7
137. Hansson GK Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 2005 352 1685 95
138. Ibrahim AI Obeid MT Jouma MJ et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts J Clin Virol 2005 32 29 32
139. Shi Y Tokunaga O Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue Pathol Int 2002 52 31 9
140. Horvath R Cerny J Benedik J Jr. Hokl J Jelinkova I Benedik J The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis J Clin Virol 2000 16 17 24
141. Musiani M Zerbini ML Muscari A et al. Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis Microbiologica 1990 13 35 41
142. Naghavi M Wyde P Litovsky S et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice Circulation 2003 107 762 8
143. Paton P Tabib A Loire R Tete R Coronary artery lesions and human immunodeficiency virus infection Res Virol 1993 144 225 31
144. Roivainen M Alfthan G Jousilahti P Kimpimaki M Hovi T Tuomilehto J Enterovirus infections as a possible risk factor for myocardial infarction Circulation 1998 98 2534 7
145. Heuschmann PU Neureiter D Gesslein M et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study Stroke 2001 32 2253 8
146. Pasceri V Cammarota G Patti G et al. Association of virulent Helicobacter pylori strains with ischemic heart disease Circulation 1998 97 1675 9
147. Higuchi Mde L Reis MM Sambiase NV et al. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction Arq Bras Cardiol 2003 81 1 11
148. Elter JR Champagne CM Offenbacher S Beck JD Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease J Periodontol 2004 75 782 90
149. Chiu B Multiple infections in carotid atherosclerotic plaques Am Heart J 1999 138 Pt 2 S534 6
150. Paquette DW The periodontal-cardiovascular link Compend Contin Educ Dent 2004 25 681 2 685 92 quiz 694
151. Zhu J Quyyumi AA Norman JE Costello R Csako G Epstein SE The possible role of hepatitis A virus in the pathogenesis of atherosclerosis J Infect Dis 2000 182 1583 7
152. Zhu J Nieto FJ Horne BD Anderson JL Muhlestein JB Epstein SE Prospective study of pathogen burden and risk of myocardial infarction or death Circulation 2001 103 45 51
153. Ouchi K Fujii B Kudo S et al. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue J Infect Dis 2000 181 Suppl. 3 S441 3
154. Saikku P Leinonen M Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 1988 2 983 6
155. Taylor-Robinson D Thomas BJ Chlamydia pneumoniae in atherosclerotic tissue J Infect Dis 2000 181 Suppl. 3 S437 40
156. Thom DH Grayston JT Siscovick DS Wang SP Weiss NS Daling JR Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease JAMA 1992 268 68 72
157. Shor A Kuo CC Patton DL Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques S Afr Med J 1992 82 158 61
158. Kuo CC Gown AM Benditt EP Grayston JT Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain Arterioscler Thromb 1993 13 1501 4
159. Kuo CC Grayston JT Campbell LA Goo YA Wissler RW Benditt EP Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) Proc Natl Acad Sci U S A 1995 92 6911 4
160. Jackson LA Campbell LA Kuo CC Rodriguez DI Lee A Grayston JT Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen J Infect Dis 1997 176 292 5
161. Higuchi M Castelli JB Aiello VD et al. Great amount of C. pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study with stable plaques Arq Bras Cardiol 2000 74 149 51
162. Muhlestein JB Anderson JL Hammond EH et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model Circulation 1998 97 633 6
163. Fong IW Chiu B Viira E Fong MW Jang D Mahony J Rabbit model for Chlamydia pneumoniae infection J Clin Microbiol 1997 35 48 52
164. Danesh J Whincup P Walker M et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis BMJ 2000 321 208 13
165. Fong IW Chiu B Viira E Jang D Mahony JB De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model Infect Immun 1999 67 6048 55
166. Laitinen K Laurila A Pyhala L Leinonen M Saikku P Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits Infect Immun 1997 65 4832 5
167. Fong IW Chiu B Mahony JB The role of Chlamydia pneumoniae in atherosclerosis - recent evidence from animal models: response Trends Microbiol 2000 8 257
168. Anderson JL Muhlestein JB Antibiotic trials for coronary heart disease Tex Heart Inst J 2004 31 33 8
169. Zhou YF Leon MB Waclawiw MA et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy N Engl J Med 1996 335 624 30
170. Zhu J Quyyumi AA Norman JE Csako G Epstein SE Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels J Am Coll Cardiol 1999 34 1738 43
171. Melnick JL Adam E DeBakey ME Possible role of cytomegalovirus in atherogenesis JAMA 1990 263 2204 7
172. Streblow DN Orloff SL Nelson JA Do pathogens accelerate atherosclerosis J Nutr 2001 131 2798S 804S
173. Nieto FJ Adam E Sorlie P et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis Circulation 1996 94 922 7
174. Blum A Giladi M Weinberg M et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis Am J Cardiol 1998 81 866 8
175. McDonald K Rector TS Braulin EA Kubo SH Olivari MT Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection Am J Cardiol 1989 64 359 62
176. Hendrix MG Dormans PH Kitslaar P Bosman F Bruggeman CA The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients Am J Pathol 1989 134 1151 7
177. Hendrix MG Salimans MM van Boven CP Bruggeman CA High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis Am J Pathol 1990 136 23 8
178. Hendrix MG Daemen M Bruggeman CA Cytomegalovirus nucleic acid distribution within the human vascular tree Am J Pathol 1991 138 563 7
179. Ridker PM Hennekens CH Stampfer MJ Wang F Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke Circulation 1998 98 2796 9
180. Haider AW Wilson PW Larson MG et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study J Am Coll Cardiol 2002 40 1408 13
181. Sorlie PD Nieto FJ Adam E Folsom AR Shahar E Massing M A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study Arch Intern Med 2000 160 2027 32
182. Muhlestein JB Horne BD Carlquist JF et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease Circulation 2000 102 1917 23
183. Potena L Grigioni F Ortolani P et al. Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study Transplantation 2003 75 839 43
184. Pampou S Gnedoy SN Bystrevskaya VB et al. Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta Virchows Arch 2000 436 539 52
185. Valantine HA Gao SZ Menon SG et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study Circulation 1999 100 61 6
186. Burns LJ Pooley JC Walsh DJ Vercellotti GM Weber ML Kovacs A Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins Transplantation 1999 67 137 44
187. Sedmak DD Knight DA Vook NC Waldman JW Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells Transplantation 1994 58 1379 85
188. Shahgasempour S Woodroffe SB Garnett HM Alterations in the expression of ELAM-1, ICAM-1 and VCAM-1 after in vitro infection of endothelial cells with a clinical isolate of human cytomegalovirus Microbiol Immunol 1997 41 121 9
189. Scholz M Blaheta RA Vogel J Doerr HW Cinatl J Jr. Cytomegalovirus-induced transendothelial cell migration. a closer look at intercellular communication mechanisms Intervirology 1999 42 350 6
190. Craigen JL Yong KL Jordan NJ et al. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration Immunology 1997 92 138 45
191. Abgueguen P Delbos V Chennebault JM Payan C Prichard E. Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review Clin Infect Dis 2003 36 E134 9
192. Rahbar A Soderberg-Naucler C Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation J Virol 2005 79 2211 20
193. Michelson S Dal Monte P Zipeto D et al. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts J Virol 1997 71 6495 500
194. Hirsch AJ Shenk T Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene J Virol 1999 73 404 10
195. Murayama T Ohara Y Obuchi M et al. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene J Virol 1997 71 5692 5
196. Bolovan-Fritts CA Trout RN Spector SA Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells J Virol 2004 78 13173 81
197. Varani S Frascaroli G Homman-Loudiyi M Feld S Landini MP Soderberg-Naucler C Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5 J Leukoc Biol 2005 77 219 28
198. Zhou YF Guetta E Yu ZX Finkel T Epstein SE Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells J Clin Invest 1996 98 2129 38
199. Carlquist JF Muhlestein JB Horne BD et al. Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36 Atherosclerosis 2004 177 53 9
200. Zhu J Quyyumi AA Norman JE et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels Am J Cardiol 2000 85 140 6
201. Blankenberg S Rupprecht HJ Bickel C et al. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease Circulation 2001 103 2915 21
202. Albert MA Danielson E Rifai N Ridker PM Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JAMA 2001 286 64 70
203. Horne BD Muhlestein JB Carlquist JF et al. Statin therapy interacts with cytomegalovirus seropositivity and high ?hangover 0>C-reactive protein in reducing mortality among patients with angiographically significant coronary disease Circulation 2003 107 258 63
204. Potena L Frascaroli G Grigioni F et al. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells Circulation 2004 109 532 6
205. Fabricant CG Fabricant J Litrenta MM Minick CR Virus-induced atherosclerosis J Exp Med 1978 148 335 40
206. Fabricant CG Fabricant J Minick CR Litrenta MM Herpesvirus-induced atherosclerosis in chickens Fed Proc 1983 42 2476 9
207. Lemstrom KB Bruning JH Bruggeman CA Lautenschlager IT Hayry PJ Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts J Clin Invest 1993 92 549 58
208. Bruggeman C Cytomegalovirus is involved in vascular pathology Am Heart J 1999 138 Pt 2 S473 5
209. Berencsi K Endresz V Klurfeld D Kari L Kritchevsky D Gonczol E Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice Cell Adhes Commun 1998 5 39 47
210. Zhou YF Shou M Guetta E et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall Circulation 1999 100 1569 75
211. Lemstrom KB Koskinen PK Bruning JH Bruggeman CA Lautenschlager IT Hayry PJ Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis Transpl Int 1994 7 Suppl. 1 S383 4
212. Lemstrom K Sihvola R Bruggeman C Hayry P Koskinen P Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat Circulation 1997 95 2614 6
213. Streblow DN Kreklywich C Yin Q et al. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants J Virol 2003 77 2182 94
214. Streblow DN Kreklywich CN Smith P et al. Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33 Am J Transplant 2005 5 436 42
215. Burnett MS Gaydos CA Madico GE et al. Atherosclerosis in apoE knockout mice infected with multiple pathogens J Infect Dis 2001 183 226 31
216. Burnett MS Durrani S Stabile E et al. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes Circulation 2004 109 893 7
217. Vliegen I Stassen F Grauls G Blok R Bruggeman C MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice J Clin Virol 2002 25 Suppl. 2 S159 71
218. Vliegen I Duijvestijn A Grauls G Herngreen S Bruggeman C Stassen F Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation Microbes Infect 2004 6 17 24
219. Blomqvist M Juhela S Erkkila S et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life Clin Exp Immunol 2002 128 511 5
220. Bach JF Infections and autoimmune diseases J Autoimmun 2005 25 Suppl. 74 80
221. Hyoty H Taylor KW The role of viruses in human diabetes Diabetologia 2002 45 1353 61
222. Clark D Human herpesvirus type 6 and multiple sclerosis Herpes 2004 11 Suppl. 2 112A 9A
223. Dewhurst S Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system Herpes 2004 11 Suppl. 2 105A 11A
224. Fotheringham J Jacobson S Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease Herpes 2005 12 4 9
225. Ohara Y Multiple sclerosis and measles virus Jpn J Infect Dis 1999 52 198 200
226. Munch M Hvas J Christensen T Moller-Larsen A Haahr S The implications of Epstein-Barr virus in multiple sclerosis - a review Acta Neurol Scand Suppl 1997 169 59 64
227. Alvarez-Lafuente R Fernandez-Gutierrez B de Miguel S et al. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction Ann Rheum Dis 2005 64 1357 9
228. Sawada S Takei M Epstein-Barr virus etiology in rheumatoid synovitis Autoimmun Rev 2005 4 106 10
229. Einsele H Steidle M Muller CA et al. Demonstration of cytomegalovirus (CMV) DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis J Rheumatol 1992 19 677 81
230. Mehraein Y Lennerz C Ehlhardt S Remberger K Ojak A Zang KD Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization Mod Pathol 2004 17 781 9
231. Triantafyllopoulou A Tapinos N Moutsopoulos HM Evidence for coxsackievirus infection in primary Sjogren's syndrome Arthritis Rheum 2004 50 2897 902
232. Newkirk MM Watanabe Duffy KN Leclerc J Lambert N Shiroky JB Detection of cytomegalovirus, Epstein-Barr virus and herpes virus-6 in patients with rheumatoid arthritis with or without Sjogren's syndrome Br J Rheumatol 1994 33 317 22
233. McClain MT Harley JB James JA The role of Epstein-Barr virus in systemic lupus erythematosus Front Biosci 2001 6 E137 47
234. Sekigawa I Nawata M Seta N Yamada M Iida N Hashimoto H Cytomegalovirus infection in patients with systemic lupus erythematosus Clin Exp Rheumatol 2002 20 559 64
235. Kasapcopur O Ergul Y Kutlug S Candan C Camcioglu Y Arisoy N Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus Rheumatol Int 2005 1 1 3
236. Severin MC Levy Y Shoenfeld Y Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit Clin Rev Allergy Immunol 2003 25 41 8
237. Wakefield AJ Fox JD Sawyerr AM et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction J Med Virol 1992 38 183 90
238. Yanai H Shimizu N Nagasaki S Mitani N Okita K Epstein-Barr virus infection of the colon with inflammatory bowel disease Am J Gastroenterol 1999 94 1582 6
239. Kishore J Ghoshal U Ghoshal UC et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome J Med Microbiol 2004 53 Pt 11 1155 60
240. Robertson DJ Sandler RS. Measles virus and Crohn's disease: a critical appraisal of the current literature Inflamm Bowel Dis 2001 7 51 7
241. Koutroubakis I Manousos ON Meuwissen SG Pena AS. Environmental risk factors in inflammatory bowel disease Hepatogastroenterology 1996 43 381 93
242. Papadakis KA Tung JK Binder SW et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease Am J Gastroenterol 2001 96 2137 42
243. Asadullah K Prosch S Audring H et al. A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression Br J Dermatol 1999 141 94 102
244. Murayama T Jisaki F Ayata M et al. Cytomegalovirus genomes demonstrated by polymerase chain reaction in synovial fluid from rheumatoid arthritis patients Clin Exp Rheumatol 1992 10 161 4
245. Hamerman D Gresser I Smith C Isolation of cytomegalovirus from synovial cells of a patient with rheumatoid arthritis J Rheumatol 1982 9 658 64
246. Tan LC Mowat AG Fazou C et al. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes Arthritis Res 2000 2 154 64
247. Hooper M Kallas EG Coffin D Campbell D Evans TG Looney RJ Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis J Rheumatol 1999 26 1452 7
248. Thorn JJ Oxholm P Andersen HK High levels of complement fixing antibodies against cytomegalovirus in patients with primary Sjogren's syndrome Clin Exp Rheumatol 1988 6 71 4
249. Burns JC Persistent cytomegalovirus infection - the etiology of Sjogren's syndrome Med Hypotheses 1983 10 451 60
250. Nawata M Seta N Yamada M Sekigawa I Lida N Hashimoto H Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus Scand J Rheumatol 2001 30 360 2
251. Stratta P Colla L Santi S et al. IgM antibodies against cytomegalovirus in SLE nephritis: viral infection or aspecific autoantibody J Nephrol 2002 15 88 92
252. Hayashi T Lee S Ogasawara H et al. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection Lupus 1998 7 561 4
253. Bulpitt KJ Brahn E Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy J Rheumatol 1989 16 677 80
254. Fujinami RS Oldstone MB Molecular mimicry as a mechanism for virus-induced autoimmunity Immunol Res 1989 8 3 15
255. Soderberg C Giugni TD Zaia JA Larsson S Wahlberg JM Moller E CD13 (human aminopeptidase N) mediates human cytomegalovirus infection J Virol 1993 67 6576 85
256. Huang G Yan Q Wang Z et al. Human cytomegalovirus in neoplastic cells of Epstein-Barr virus negative Hodgkin's disease Int J Oncol 2002 21 31 6
257. Pacsa AS Kummerlander L Pejtsik B Pali K Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls J Natl Cancer Inst 1975 55 775 81
258. Mackowiak PA Microbial oncogenesis Am J Med 1987 82 79 97
259. Eiben GL da Silva DM Fausch SC Le Poole IC Nishimura MI Kast WM Cervical cancer vaccines: recent advances in HPV research Viral Immunol 2003 16 111 21
260. Syrjanen S Human papillomavirus (HPV) in head and neck cancer J Clin Virol 2005 32 Suppl. 1 S59 66
261. Bosch FX Ribes J Cleries R Diaz M Epidemiology of hepatocellular carcinoma Clin Liver Dis 2005 9 191 211
262. Serraino D Piselli P Angeletti C Scuderi M Ippolito G Capobianchi MR Infection with Epstein-Barr virus and cancer: an epidemiological review J Biol Regul Homeost Agents 2005 19 63 70
263. Vilchez RA Butel JS Simian virus 40 and its association with human lymphomas Curr Oncol Rep 2003 5 372 9
264. Cinatl J Jr. Vogel JU Kotchetkov R Wilhelm Doerr H Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression FEMS Microbiol Rev 2004 28 59 77
265. Cinatl J Jr. Scholz M Doerr HW Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation Med Res Rev 2005 25 167 85
266. Cinatl J Scholz M Kotchetkov R Vogel JU Doerr HW Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology Trends Mol Med 2004 10 19 23
267. Kalejta RF Shenk T Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein Proc Natl Acad Sci U S A 2003 100 3263 8
268. Kalejta RF Bechtel JT Shenk T Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors Mol Cell Biol 2003 23 1885 95
269. Boldogh I AbuBakar S Albrecht T Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection Science 1990 247 561 4
270. Murphy JC Fischle W Verdin E Sinclair JH Control of cytomegalovirus lytic gene expression by histone acetylation EMBO J 2002 21 1112 20
271. Nevels M Paulus C Shenk T Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation Proc Natl Acad Sci U S A 2004 101 17234 9
272. Spiller OB Borysiewicz LK Morgan BP Development of a model for cytomegalovirus infection of oligodendrocytes J Gen Virol 1997 78 Pt 12 3349 56
273. Chen Z Knutson E Kurosky A Albrecht T Degradation of p21cip1 in cells productively infected with human cytomegalovirus J Virol 2001 75 3613 25
274. Scholz M Blaheta RA Wittig B et al. Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5) Tissue Antigens 2000 55 412 21
275. Blaheta RA Beecken WD Engl T et al. Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness Neoplasia 2004 6 323 31
276. Reboredo M Greaves RF Hahn G Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication J Gen Virol 2004 85 Pt 12 3555 67
277. Goldmacher VS Bartle LM Skaletskaya A et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2 Proc Natl Acad Sci U S A 1999 96 12536 41
278. Colberg-Poley AM Patel MB Erezo DP Slater JE Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria J Gen Virol 2000 81 Pt 7 1779 89
279. Skaletskaya A Bartle LM Chittenden T McCormick AL Mocarski ES Goldmacher VS A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation Proc Natl Acad Sci U S A 2001 98 7829 34
280. Zhu H Shen Y Shenk T Human cytomegalovirus IE1 and IE2 proteins block apoptosis J Virol 1995 69 7960 70
281. Cinatl J Jr. Cinatl J Vogel JU et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells Cancer Res 1998 58 367 72
282. Pereg D Lishner M Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer J Intern Med 2005 258 115 23
283. Martelius TJ Wolff H Bruggeman CA Hockerstedt KA Lautenschlager IT Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat Transpl Int 2002 15 610 4
284. Rue CA Jarvis MA Knoche AJ et al. A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism J Virol 2004 78 12529 36
285. Zhu H Cong JP Yu D Bresnahan WA Shenk TE From the cover: inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication Proc Natl Acad Sci U S A 2002 99 3932 7
286. Speir E Yu ZX Ferrans VJ Huang ES Epstein SE Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells Circ Res 1998 83 210 6